AEON Biopharma, Inc. SEC filings AEON
AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 26, 2026 | Oct 26, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 13, 2026 | Oct 13, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| DEF 14A | Proxy statement | Dec 29, 2025 | Dec 29, 2025 |
| PRE 14A | Preliminary proxy statement | Dec 19, 2025 | Dec 19, 2025 |
| DEFA14A | Additional proxy material | Nov 14, 2025 | — |
| DEFA14A | Additional proxy material | Nov 13, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jan 23, 2025 | Feb 24, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 13, 2025 | Feb 24, 2025 |
| DEFA14A | Additional proxy material | May 14, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2024 | Jun 14, 2024 |
| DEFA14A | Additional proxy material | Jun 30, 2023 | — |
| DEFA14A | Additional proxy material | Jun 30, 2023 | — |
| DEFA14A | Additional proxy material | Jun 28, 2023 | — |
| DEFA14A | Additional proxy material | Jun 26, 2023 | — |
| DEFA14A | Additional proxy material | Jun 21, 2023 | — |
| DEFA14A | Additional proxy material | Jun 15, 2023 | — |
| DEFA14A | Additional proxy material | Jun 13, 2023 | — |
| DEFA14A | Additional proxy material | Jun 9, 2023 | — |
| DEFA14A | Additional proxy material | Jun 6, 2023 | — |
| DEFM14A | Filing | May 12, 2023 | — |
| DEFA14A | Additional proxy material | Feb 6, 2023 | — |
| DEFA14A | Additional proxy material | Jan 23, 2023 | — |
| DEF 14A | Proxy statement | Dec 22, 2022 | Jan 24, 2023 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2022 | Dec 12, 2022 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AEON (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837607
- Former names
- Priveterra Acquisition Corp. (until Jul 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.